Treating Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome: To Obi or Not to Obi, That is the Question

Clin J Am Soc Nephrol. 2023 Dec 1;18(12):1527-1529. doi: 10.2215/CJN.0000000000000344. Epub 2023 Oct 26.

Authors

Cal H Robinson^{1

2}, Rulan S Parekh^{1

2

3}

Affiliations

¹ Division of Nephrology, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.
² Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.
³ Division of Nephrology, Department of Medicine, Women's College Hospital and University of Toronto, Toronto, Ontario, Canada.

PMID: 37883188
PMCID: PMC10723921 (available on 2024-12-01)
DOI: 10.2215/CJN.0000000000000344

No abstract available

Publication types

Editorial

MeSH terms

Glucocorticoids / therapeutic use
Humans
Immunosuppressive Agents / adverse effects
Nephrotic Syndrome* / diagnosis
Nephrotic Syndrome* / drug therapy
Recurrence

Substances

Immunosuppressive Agents
Glucocorticoids